Incidence and predictors of major bleeding among patients receiving apixaban or aspirin for subclinical atrial fibrillation: insights from the ARTESiA sub-analysis
Event:
EHRA 2025
Topic:
Oral Anticoagulation
Session:
Clinical aspects in atrial fibrillation care
